Deepa is a partner in Goodwin’s Life Sciences group. Deepa has years of experience working on corporate transactions for high-growth biotechnology, medical device, diagnostic, healthcare, and digital health companies. She also regularly represents venture capital funds and underwriters in the Life Sciences industry. Deepa advises management and boards of directors on corporate governance and critical strategic matters – from general corporate, startup issues, public company reporting, market communications, and market regulatory issues to acquisitions, corporate development, and capital market strategies. Deepa also has extensive financing experience, ranging from seed investment and venture capital through cross-over financings and public company securities offerings, such as initial public offerings, follow-ons, confidentially marketed public offerings (CMPOs), registered directs, and private investments in public equity. She also handles regulatory matters involving the U.S. Securities and Exchange Commission and stock exchanges. Deepa has advised buyers and sellers in a wide range of mergers and acquisitions.